Company / Working Capital per Share
ImmunityBio, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.30
FY2025
5-year range
-$0.91 / $0.56
FY2021-FY2025
Trend
+53.6%
vs FY2024
Sector context
#200 of 210
Health Care
What the data says
Among 210 Health Care companies, ImmunityBio, Inc. is in the bottom 5% for working capital per share. Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.91 in FY2022 to $2.37 in FY2016.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of -7.7%.
Declined from $0.56 to $0.30 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 210This company $0.30 Sector average $118.60
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 53.6% year-over-year.
- Ranks #200 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +53.6% |
| FY2024 | $0.19 | -65.5% |
| FY2023 | $0.56 | +161.8% |
| FY2022 | -$0.91 | -899.1% |
| FY2021 | -$0.09 | -120.5% |
| FY2020 | $0.44 | -20.8% |
| FY2019 | $0.56 | -28.2% |
| FY2018 | $0.78 | -42.8% |
| FY2017 | $1.36 | -42.5% |
| FY2016 | $2.37 | -99.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026